Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
11/2004
11/17/2004EP1477486A2 Imides as inhibitors of TNF alpha
11/17/2004EP1477478A2 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses.
11/17/2004EP1477167A1 [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl derivatives as beta2 agonists
11/17/2004EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004EP1263727B1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
11/17/2004EP1087953B1 Nitrate salts of antihypertensive medicines
11/17/2004EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/17/2004EP1060175B1 Tryptase inhibitors
11/17/2004EP1042276B1 Thiourea compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
11/17/2004CN1546461A Theanine extraction process
11/16/2004US6818638 Melvinolin derivatives
11/16/2004US6818635 For therapy of bacterial infections and neoplasms,
11/16/2004US6818634 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
11/16/2004CA2092306C Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity
11/11/2004WO2004056745A3 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
11/11/2004WO2003079983A3 Methods of preparing substituted tetracyclines with transition metal-based chemistries
11/11/2004US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004US20040224991 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
11/11/2004US20040224941 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/11/2004US20040224928 For therapy of bacterial infections and neoplasms,
11/11/2004US20040224927 7-N-substituted phenyl tetracycline compounds
11/11/2004US20040224925 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
11/11/2004US20040224924 Programming a specific course and rate for a parent drug compound's metabolism that leads to an inactive or weakly active and non-toxic metabolite when the parent drug compound is administered, comprising modifying the parent drug compound by forming one or more of a predetermined chemical arrangement
11/10/2004EP1474408A1 N-phenyl-2-pyrimidine-amine derivatives
11/10/2004EP1474380A2 4-dedimethylamino tetracycline compounds
11/10/2004EP1246793B1 Substituted aminomethyl-phenyl-cyclohexane derivatives
11/10/2004EP1137690B1 Peg-based macromonomers, chemically inert polymers prepared therefrom and the use of these polymers for organic synthesis and enzyme reactions
11/10/2004EP1085009B1 Indan derivatives
11/10/2004EP1077930B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/09/2004US6815388 Method for activating passivated iron
11/04/2004WO2004094464A1 Oligopeptides, composition and use thereof as elicitors of the natural defences of plants
11/04/2004WO2004073703B1 Glycinamide derivative for inhibiting hiv replication
11/04/2004WO2003087044A3 Novel carboxamide compounds for use in mch receptor related disorders
11/04/2004WO2003077847A3 Substituted amides
11/04/2004US20040220272 Renin inhibitors; treating cardiovascular disorders and glaucoma
11/04/2004US20040220222 Malonamide derivatives
11/04/2004US20040220150 pure antibiotic
11/04/2004US20040220079 Inhibitors of Memapsin 2 and use thereof
11/03/2004EP1472214A2 Compounds for inhibiting insulin secretion and methods related thereto
11/03/2004EP1252209B1 Compositions comprising antioxidant amines based on n-(4-anilinophenyl) amides
11/03/2004CN1173946C Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound
11/02/2004US6811833 Birefringement film
10/2004
10/28/2004WO2004091724A1 Anthranilic acid derivatives useful in treating infection with hepatitis c virus
10/28/2004WO2004091513A2 9-aminomethyl substituted minocycline compounds
10/28/2004WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/28/2004US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004US20040214867 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals
10/28/2004US20040214846 A heteroaryl carbamic acid, secondary amide or amine, or phthalimidoyl derivatives; prevent from getting the disease or condition; cognitive impairment, Down's syndrome, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type, cerebral amyloid angiopathy, neurodegenerative disease
10/28/2004US20040214801 9-Substituted minocycline compounds
10/27/2004EP1471052A1 Geranyl compounds
10/27/2004EP1470102A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps)
10/27/2004EP1470101A1 New opioid derivative
10/27/2004EP1212269B1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
10/27/2004CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
10/26/2004US6809176 Compounds for use in treatment of cancer
10/26/2004US6809093 Drug resistance therapy
10/26/2004CA2181238C Lewis acid catalyzed ammonolysis of nylon
10/26/2004CA2157374C Reaction products of amino alkylene carboxylic acids and petroleum middle distillates containing them
10/21/2004WO2004089881A1 New sulfonyl derivatives of aminonaphtols
10/21/2004WO2004089877A1 New hydroxynaphthyl amides
10/21/2004WO2004089874A1 Biphenyl carboxylic amide p38 kinase inhibitors
10/21/2004US20040210079 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease
10/21/2004US20040210051 Inhibitors of binding between vascular cell adhesion molecules and cells expressing vla-4 integrin; antiinflammatory agents
10/21/2004US20040209957 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke
10/21/2004US20040208822 technetium labelled complexes; for the treatment or diagnosis of pathologies caused by attack on human cartilage, arthritis
10/21/2004CA2521228A1 Biphenyl carboxylic amide p38 kinase inhibitors
10/20/2004EP1467968A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
10/20/2004EP1467965A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
10/20/2004EP1289936B1 Substituted stilbenes as glucose uptake enhancers
10/20/2004EP0907625A4 Fluorous reaction and separation systems
10/20/2004EP0830136B1 New cryptophycins from synthesis
10/20/2004CN1538951A Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells
10/20/2004CN1538950A Method for producton of amines by reductive amination of carbonyl compounds under transfer-hydrogemation conditons
10/20/2004CN1538842A Atineoplastic combinations
10/20/2004CN1537879A Tree type molecule and its preparation method and use
10/20/2004CN1171858C Polyasparacyl-L-arginine, its preparation and medical application
10/19/2004WO2004069773A1 Irreversible caspase-3 inhibitors as active site probes
10/19/2004US6806365 N-alkanoylphenylalamine derivatives
10/19/2004US6806287 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/19/2004CA2514441A1 Irreversible caspase-3 inhibitors as active site probes
10/13/2004EP1466888A1 Calcium receptor-active arylalkyl amines
10/13/2004EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
10/13/2004EP1465860A4 An improved process for the synthesis of ( ) 2-amino-n-[2,(s,5-dimethoxyphenyl)-2-hydroxyethyl] acetamide monohydrochloride
10/13/2004EP1465860A1 An improved process for the synthesis of ( ) 2-amino-n-[2,(s,5-dimethoxyphenyl)-2-hydroxyethyl] acetamide monohydrochloride
10/13/2004EP1169038A4 Cyclic protein tyrosine kinase inhibitors
10/12/2004US6803485 Process for the preparation of iopamidol
10/12/2004US6803384 Diaminopropionic acid derivatives
10/12/2004US6803383 Utilizing selective inhibitors of the binding of integrin alpha v beta 3 with matrix metalloproteinase 2
10/12/2004US6803378 For therapy and prophylaxis of acquired immune deficiency syndrome (aids), or arc
10/07/2004WO2004085388A2 Cyclic protein tyrosine kinase inhibitors
10/07/2004WO2004085378A1 Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation
10/07/2004WO2004084842A2 Inhibitors of cathepsin s
10/07/2004WO2004014350A3 Polymer conjugates of a local anaesthetic drug
10/07/2004US20040198836 reacting 1-(2,5-dimethoxyphenyl)-2-bromoethanone with hexamine, then acylating with haloacetylchloride and sodium acetate, selectively reducing with sodium borohydride and stannous chloride, and quaternization, to form midodrine and salts, used as hypertensive agents
10/07/2004US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration
10/07/2004US20040198780 osteoporosis; antiarthritic agents; antidiabetic aghents; Alzheimer's disease; shock; central nervous system disorders; anticancer agents
10/06/2004EP1463719A2 Eponemycin and epoxomicin analogs and uses thereof
10/06/2004EP1252134B1 Method for producing acetoacetylated aromatic amines
10/06/2004CN1169782C Method for synthesizing theanine
10/05/2004US6800769 Chemical intermediates
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 162